40 APV29005 involverer 25 patienter mellem 6 og 11 år (hvoraf de fleste behandles med 18 mg fosamprenavir/ kg og 3 mg ritonavir/ kg 2 gange daglig eller voksendoseringen) og 29 patienter mellem 12 og 18 år (hvoraf de fleste behandles med voksendoseringen).
APV29005 enrolled 25 patients aged 6 to 11 (the majority of whom were treated with fosamprenavir / ritonavir 18/ 3 mg/ kg twice daily or the adult tablet regimen) and 29 patients aged 12 to 18 (the majority of whom were treated with the adult tablet regimen).